Search

everythinglearnresearchcommunity

for

Search:↓

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

The Mediterranean dwarf palm has medicinal, nutritional, and craft uses, but more research is needed.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Baricitinib shows promise in treating severe hair loss.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Combining rosemary oil with light therapy may improve hair loss treatment.

Some bacteria use arsenic compounds as antibiotics, and others have evolved resistance; a particular arsenic-based compound shows potential as a new antimalarial treatment.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Alopecia Areata is linked to higher depression levels.

The medicine Diane is effective in treating hair loss, severe acne, and excessive hair growth.